Synthetic peptides inhibit adhesion of human tumor cells to extracellular matrix proteins

Citation
Ib. Deroock et al., Synthetic peptides inhibit adhesion of human tumor cells to extracellular matrix proteins, CANCER RES, 61(8), 2001, pp. 3308-3313
Citations number
52
Categorie Soggetti
Oncology,"Onconogenesis & Cancer Research
Journal title
CANCER RESEARCH
ISSN journal
00085472 → ACNP
Volume
61
Issue
8
Year of publication
2001
Pages
3308 - 3313
Database
ISI
SICI code
0008-5472(20010415)61:8<3308:SPIAOH>2.0.ZU;2-N
Abstract
Human tumor cell progression and metastasis are partially dependent on the ability of a tumor cell to adhere to the proteins of the extracellular matr ix (ECM) and survive at the distant location. Ex novel D-amino acid-contain ing peptides were analyzed for their ability to adhere to human prostate tu mor cells, support tumor cell adhesion, and inhibit tumor cell adhesion to ECR;I proteins or human dermal fibroblasts. Of these, two peptides called R Z-3 (kmviywkag) and HYD-1 (kikmviswkg) bound to tumor cell surfaces and com pared favorably with the previously reported AG-73 (RKRLQVQLSIRT) L-amino a cid peptide, as determined by fluorescence-activated cell sorting analysis. A scrambled peptide derivative of HYD-1, called HYDS-1 (wiksmkivkg), was n ot active. The RZ-3, HYD-1, and AG-73 peptides supported maximal cancer cel l adhesion at 5 mug, 10 mug, and 50 mug/well, respectively. The ECM protein s fibronectin, laminin I, and collagen IV supported maximal cell adhesion a t 1 mug, >10 mug, and 50 mug/well, respectively. Prostate tumor cell adhesi on to immobilized RZ-3 and HYD-1 peptides was inhibited by alpha2-6- and be ta1-integrin-blocking antibodies. Conversely, tumor cell adhesion to a beta 1-integrin-specific antibody was blocked by both RZ-3 and HYD-1. Epithelial cell adhesion to dermal fibroblasts was inhibited by HYD-1 and unaffected by the scrambled peptide, HYDS-1. Cell adhesion to immobilized peptides was unaffected by EDTA. The soluble RZ-3 and HYD-1 peptides inhibited tumor ce ll adhesion to each of the immobilized four ECM proteins (1.0 mug/well) in a time- and concentration-dependent manner. The IC50 of the RZ-3 peptide fo r blacking adhesion to fibronectin, laminin 1, laminin 5, and collagen TV w as 2.4 mug, 1.8 mug, 4.6 mug, and 2.8 mug/well, respectively. The IC50 of t he HYD-1 peptide for blocking adhesion to fibronectin, laminin 1, laminin 5 , and collagen IV was 6.9 mug, 5.7 mug, >10 mug, and 6.2 mug/well, respecti vely. Taken together, these results indicate that RZ-3 and HYD-1 are biolog ically active D-amino acid-containing peptides that can themselves support tumor cell adhesion and can inhibit tumor cell adhesion to immobilized ECM proteins or dermal fibroblasts.